K906-1243 Screening compound: 2-(2,1,3-benzothiadiazole-4-sulfonamido)-N-(2-ethoxyphenyl)-2-phenylacetamide

K906-1243 Screening compound: 2-(2,1,3-benzothiadiazole-4-sulfonamido)-N-(2-ethoxyphenyl)-2-phenylacetamide
K906-1243 Screening compound: 2-(2,1,3-benzothiadiazole-4-sulfonamido)-N-(2-ethoxyphenyl)-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K906-1243
2-(2,1,3-benzothiadiazole-4-sulfonamido)-N-(2-ethoxyphenyl)-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K906-1243

Molecular Formula

C22H20N4O4S2 (C22 H20 N4 O4 S2)

Compound Name

2-(2,1,3-benzothiadiazole-4-sulfonamido)-N-(2-ethoxyphenyl)-2-phenylacetamide

IUPAC name

2-(213-benzothiadiazole-4-sulfonamido)-N-(2-ethoxyphenyl)-2-phenylacetamide

SMILES

CCOc(cccc1)c1NC(C(c1ccccc1)NS(c1cccc2nsnc12)(=O)=O)=O

InChI

InChI=1S/C22H20N4O4S2/c1-2-30-18-13-7-6-11-16(18)23-22(27)20(15-9-4-3-5-10-15)26-32(28,29)19-14-8-12-17-21(19)25-31-24-17/h3-14,20,26H,2H2,1H3,(H,23,27)/t20-/m1/s1

InChI Key

PPYJDHQEQDUAPK-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD15112306

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.56

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.834

Distribution Coefficient, logD

3.776

Water Solubility, LogSw

-3.95

Polar Surface Area

92.119

Acid Dissociation Constant (pKa)

8.24

Base Dissociation Constant (pKb)

-1.28

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

13.60

K906-1243 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

Human Proteases Annotated Library (2868 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Others
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with K906-1243 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K906-1243?
Check Price and Availability of K906-1243, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K906-1243 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K906-1243
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K906-1243
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K906-1243 available by request